Algert Global LLC Glycomimetics Inc Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.15 $15,122 - $32,204	-28,004 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.0 - $1.58 $1,830 - $2,891	1,830 Added 6.99%	28,004 $32,000
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $21,067 - $31,308	14,630 Added 126.73%	26,174 $38,000
Q3 2021 Nov 15, 2021	BUY	$1.8 - $2.39 $20,779 - $27,590	11,544 New	11,544 $25,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.